Caliber Newsroom

Big Pharma’s reputation returns to normal levels in the post-pandemic era, but the industry must connect products, innovation, and leadership with societal impact to improve trust

October 27, 2023

Big Pharma’s reputation returns to normal levels in the post-pandemic era, but the industry must connect products, innovation, and leadership with societal impact to improve trust

DENMARK, 26th January 2023A new study published by Caliber has found that the reputation of the global pharmaceutical sector is returning to normal levels in the post-pandemic era. However, the ind...
Read More